skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: DOAJ Directory of Open Access Journals remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
467 Anti-EGFR antibody added to ongoing anti-PD-1 antibody treatment for metastatic cutaneous squamous cell carcinoma of the face: two case reports
467 Anti-EGFR antibody added to ongoing anti-PD-1 antibody treatment for metastatic cutaneous squamous cell carcinoma of the face: two case reports
Material Type:
Artigo 		Adicionar ao Meu Espaço

467 Anti-EGFR antibody added to ongoing anti-PD-1 antibody treatment for metastatic cutaneous squamous cell carcinoma of the face: two case reports

Eton, Omar ; Hsu, Emily ; Patel, Akshay ; Cartun, Richard ; Earle, Jonathan ; Mnayer, Laila ; Yu, Peter ; Kotowitz, Jennifer

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A496-A497 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
2
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
Material Type:
Artigo 		Adicionar ao Meu Espaço

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810

Falchook, Gerald S ; Leidner, Rom ; Stankevich, Elizabeth ; Piening, Brian ; Bifulco, Carlo ; Lowy, Israel ; Fury, Matthew G

Journal for immunotherapy of cancer, 2016-11, Vol.4 (1), p.70-70, Article 70 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Rischin, Danny ; Khushalani, Nikhil I ; Schmults, Chrysalyne D ; Guminski, Alexander ; Chang, Anne Lynn S ; Lewis, Karl D ; Lim, Annette M ; Hernandez-Aya, Leonel ; Hughes, Brett G M ; Schadendorf, Dirk ; Hauschild, Axel ; Thai, Alesha A ; Stankevich, Elizabeth ; Booth, Jocelyn ; Yoo, Suk-Young ; Li, Siyu ; Chen, Zhen ; Okoye, Emmanuel ; Chen, Chieh-I ; Mastey, Vera ; Sasane, Medha ; Lowy, Israel ; Fury, Matthew G ; Migden, Michael R

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002757 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
4
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Babiker, Hani ; Brana, Irene ; Mahadevan, Daruka ; Owonikoko, Taofeek ; Calvo, Emiliano ; Rischin, Danny ; Moreno, Victor ; Papadopoulos, Kyriakos P. ; Crittenden, Marka ; Formenti, Silvia ; Giralt, Jordi ; Garrido, Pilar ; Soria, Ainara ; Hervás‐Morón, Asunción ; Mohan, Kosalai Kal ; Fury, Matthew ; Lowy, Israel ; Mathias, Melissa ; Feng, Minjie ; Li, Jingjin ; Stankevich, Elizabeth

The oncologist (Dayton, Ohio), 2021-09, Vol.26 (9), p.e1508-e1513 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
5
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

Rischin, Danny ; Migden, Michael R ; Lim, Annette M ; Schmults, Chrysalyne D ; Khushalani, Nikhil I ; Hughes, Brett G M ; Schadendorf, Dirk ; Dunn, Lara A ; Hernandez-Aya, Leonel ; Chang, Anne Lynn S ; Modi, Badri ; Hauschild, Axel ; Ulrich, Claas ; Eigentler, Thomas ; Stein, Brian ; Pavlick, Anna C ; Geiger, Jessica L ; Gutzmer, Ralf ; Alam, Murad ; Okoye, Emmanuel ; Mathias, Melissa ; Jankovic, Vladimir ; Stankevich, Elizabeth ; Booth, Jocelyn ; Li, Siyu ; Lowy, Israel ; Fury, Matthew G ; Guminski, Alexander

Journal for immunotherapy of cancer, 2020-06, Vol.8 (1), p.e000775 [Periódico revisado por pares]

England: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
6
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Material Type:
Artigo 		Adicionar ao Meu Espaço

The biology of Hepatocellular carcinoma: implications for genomic and immune therapies

Khemlina, Galina ; Ikeda, Sadakatsu ; Kurzrock, Razelle

Molecular cancer, 2017-08, Vol.16 (1), p.149-149, Article 149 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance

Pu, Xingxiang ; Wu, Lin ; Su, Dan ; Mao, Weimin ; Fang, Bingliang

BMC cancer, 2018-11, Vol.18 (1), p.1082-1082, Article 1082 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer

Karaboué, Abdoulaye ; Collon, Thierry ; Pavese, Ida ; Bodiguel, Viviane ; Cucherousset, Joel ; Zakine, Elda ; Innominato, Pasquale F ; Bouchahda, Mohamed ; Adam, René ; Lévi, Francis

Cancers, 2022-02, Vol.14 (4), p.896 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
9
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
Material Type:
Artigo 		Adicionar ao Meu Espaço

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

Lipson, Evan J ; Lilo, Mohammed T ; Ogurtsova, Aleksandra ; Esandrio, Jessica ; Xu, Haiying ; Brothers, Patricia ; Schollenberger, Megan ; Sharfman, William H ; Taube, Janis M

Journal for immunotherapy of cancer, 2017-03, Vol.5 (1), p.23, Article 23 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective

Wang, Jun ; Yuan, Ruirong ; Song, Wenru ; Sun, Jingwei ; Liu, Delong ; Li, Zihai

Journal of hematology and oncology, 2017-01, Vol.10 (1), p.34-34, Article 34 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2014  (2)
  2. 2014Até2015  (3)
  3. 2016Até2017  (8)
  4. 2018Até2020  (14)
  5. Após 2020  (36)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.